Wellgistics Health, Inc. (NASDAQ:WGRX) announced on May 8, 2025, in Tampa, Florida, a new initiative to use XRP for treasury reserves and real-time payments. This move aims to make Wellgistics one of the first publicly traded healthcare companies to deploy XRP in this manner. The initiative is supported by a $50 million Equity Line of Credit (ELOC).
The company believes this will eliminate banking delays, reduce costs, and increase transparency across its healthcare network. XRP settles transactions in 3-5 seconds at a cost of less than $0.0002 per transfer. This compares favorably to the 1-3 days and $10-$30 cost for traditional ACH or wire transfers.
Wellgistics Health aims to leverage XRP for real-time settlements, smart rebates, and XRP-backed credit lines. They also plan to use it for global vendor payouts and compliance reporting. CME Group will launch XRP futures in May 2025, and Mastercard has identified XRP as a bridge currency for cross-border payments.
Ripple's acquisition of Hidden Road and regulatory licensing in Dubai further support XRP's adoption. Ripple is also expanding cross-border payment corridors in Brazil and Portugal. Wellgistics Health believes its XRP initiative positions it ahead of the curve in healthcare and fintech.
Wellgistics Health operates across pharmaceutical distribution, prescription technology, and clinical fulfillment. It connects over 150 direct manufacturer contracts to a network of more than 6,000 independent pharmacies.
This article is based on our author's analysis of materials taken from the following resource: ACCESS Newswire.